Overview


According to FutureWise analysis the market for healthcare (OEM) in 2023 is US$ 0.14 billion, and is expected to reach US$ 0.31 billion by 2031 at a CAGR of 10.02%.

Original equipment manufacturers (OEMs) produce products that are sold by other manufacturers on their own. OEM products are components in the fabrication of a final end product. Healthcare OEM (original equipment manufacturer) market growth and demand are expected to be driven by the increasing importance of patient safety. Moreover, the increase in frequency of diseases and the requirement for early diagnosis to ensure patient safety and health is also expected to drive the global healthcare original equipment manufacturer (OEM) market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Healthcare (OEM) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Healthcare (OEM) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Johnson and Johnson Services, Inc.
  • General Electric Company
  • Siemens Healthcare GmbH
  • Baxter
  • Koninklijke Philips N.V.
  • Toshiba International Corporation
  • FUJIFILM Holdings America Corporation
  • Hitachi Healthcare Americas
  • ESAOTE SPA
  • Drägerwerk AGCo. KGaA
  • Accenture
  • Cognizant
  • Allscripts Healthcare, LLC
  • IBM
  • Wipro Limited
  • Tata Consultancy Services Ltd.
  • Medtronic
  • Abbott
  • BD
  • Boston Scientific Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Healthcare Software
  • Medical Device
  • Instruments
  • Others

By OEM Solutions

  • Quality control and Regulatory Compliance
  • Manufacturing and Fabrication
  • Packaging and Sterilization
  • Product Design and Development
  • Order Fulfillment and Flexible Distribution
  • Technical Support
  • Project Management
  • Others

By Application

  • Healthcare Administration
  • Dentistry
  • Surgery
  • Laboratory
  • Veterinary
  • Pharmaceutical and cosmetics
  • Ophthalmology
  • Dialysis
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Healthcare (OEM) Market By Type, By OEM Solutions, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Healthcare (OEM) Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Healthcare (OEM) Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Healthcare (OEM) Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Healthcare (OEM) Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Healthcare Software
        2. Medical Device
        3. Instruments
        4. Others

  • 8.   Healthcare (OEM) Market, By OEM Solutions Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Quality control and Regulatory Compliance
        2. Manufacturing and Fabrication
        3. Packaging and Sterilization
        4. Product Design and Development
        5. Order Fulfillment and Flexible Distribution
        6. Technical Support
        7. Project Management
        8. Others

  • 9.   Healthcare (OEM) Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Healthcare Administration
        2. Dentistry
        3. Surgery
        4. Laboratory
        5. Veterinary
        6. Pharmaceutical and cosmetics
        7. Ophthalmology
        8. Dialysis
        9. Others

  • 10.   North America Healthcare (OEM) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Healthcare (OEM) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Healthcare (OEM) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Healthcare (OEM) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Johnson & Johnson Services, Inc.
               1.1. Company Overview
               1.2. Product Portfolio
            1.3. SWOT Analysis
            1.4. Financial Overview
            1.5. Strategic Overview
        2. General Electric Company
            2.1. Company Overview
            2.2. Product Portfolio
            2.3. SWOT Analysis
            2.4. Financial Overview
            2.5. Strategic Overview
        3. Siemens Healthcare GmbH
            3.1. Company Overview
            3.2. Product Portfolio
            3.3. SWOT Analysis
            3.4. Financial Overview
            3.5. Strategic Overview
        4. Baxter
            4.1. Company Overview
            4.2. Product Portfolio
            4.3. SWOT Analysis
            4.4. Financial Overview
            4.5. Strategic Overview
        5. Koninklijke Philips N.V.
            5.1. Company Overview
            5.2. Product Portfolio
            5.3. SWOT Analysis
            5.4. Financial Overview
            5.5. Strategic Overview
        6. Toshiba International Corporation
            6.1. Company Overview
            6.2. Product Portfolio
            6.3. SWOT Analysis
            6.4. Financial Overview
            6.5. Strategic Overview
        7. FUJIFILM Holdings America Corporation
               7.1. Company Overview
            7.2. Product Portfolio
            7.3. SWOT Analysis
            7.4. Financial Overview
            7.5. Strategic Overview
        8. Hitachi Healthcare Americas
            8.1. Company Overview
            8.2. Product Portfolio
            8.3. SWOT Analysis
               8.4. Financial Overview
            8.5. Strategic Overview
        9. ESAOTE SPA
            9.1. Company Overview
            9.2. Product Portfolio
            9.3. SWOT Analysis
            9.4. Financial Overview
            9.5. Strategic Overview
        10. Drägerwerk AGCo. KGaA
            10.1. Company Overview
            10.2. Product Portfolio
            10.3. SWOT Analysis
            10.4. Financial Overview
            10.5. Strategic Overview
        11. Accenture
            11.1. Company Overview
            11.2. Product Portfolio
            11.3. SWOT Analysis
            11.4. Financial Overview
            11.5. Strategic Overview
        12. Cognizant
            12.1. Company Overview
            12.2. Product Portfolio
            12.3. SWOT Analysis
            12.4. Financial Overview
            12.5. Strategic Overview
        13. Allscripts Healthcare, LLC
            13.1. Company Overview
            13.2. Product Portfolio
            13.3. SWOT Analysis
            13.4. Financial Overview
            13.5. Strategic Overview
        14. IBM
            14.1. Company Overview
            14.2. Product Portfolio
            14.3. SWOT Analysis
            14.4. Financial Overview
            14.5. Strategic Overview
        15. Wipro Limited
            15.1. Company Overview
            15.2. Product Portfolio
            15.3. SWOT Analysis
            15.4. Financial Overview
            15.5. Strategic Overview
        16. Tata Consultancy Services Ltd.
            16.1. Company Overview
            16.2. Product Portfolio
            16.3. SWOT Analysis
            16.4. Financial Overview
            16.5. Strategic Overview
        17. Medtronic
             17.1. Company Overview
             17.2. Product Portfolio
             17.3. SWOT Analysis
          17.4. Financial Overview
          17.5. Strategic Overview
         18. Abbott
          18.1. Company Overview
          18.2. Product Portfolio
          18.3. SWOT Analysis
          18.4. Financial Overview
          18.5. Strategic Overview
        19. BD
          19.1. Company Overview
          19.2. Product Portfolio
          19.3. SWOT Analysis
          19.4. Financial Overview
          19.5. Strategic Overview
        20. Boston Scientific Corporation
           20.1. Company Overview
           20.2. Product Portfolio
           20.3. SWOT Analysis
              20.4. Financial Overview
           20.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients